Home › Kidney Cancer (Renal Cell Carcinoma) › Arkansas › Springdale
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Springdale, AR
3 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Springdale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RecruitingPhase 2
- Highlands Oncology Group, Springdale
- Highlands Oncology Group - Rogers, Rogers · 10 mi away
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- Highlands Oncology Group, PA, Springdale
- Highlands Oncology Group, Rogers · 10 mi away
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
RecruitingPhase 3
- Highlands Oncology Group, Springdale
- Highlands Oncology Group - Rogers, Rogers · 10 mi away
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX34 studies
- New York City, NY29 studies
- St. Louis, MO25 studies
- Dallas, TX24 studies
- Nashville, TN24 studies
- Los Angeles, CA22 studies
- Boston, MA16 studies
- Philadelphia, PA16 studies
- Queens, NY16 studies
- Pittsburgh, PA15 studies
- Baldwin Park, CA15 studies
- Edison, NJ14 studies
Other studies in Springdale
- Non-Small Cell Lung Cancer15 studies
- Schizophrenia8 studies
- Metastatic Cancer6 studies
- Lung Cancer6 studies
- Breast Cancer5 studies
- Cancer (all types)5 studies
- Colorectal Cancer5 studies
- Bladder Cancer4 studies
- Ovarian Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Multiple Myeloma3 studies
- Small Cell Lung Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.